Submitted by Anonymous (not verified) on 25 February 2026 - 15:42
Opinion/decision on a Paediatric investigation plan (PIP): Rizmoic, naldemedine tosilate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: EMA/PE/0000226303
Source: